All Posts By

Smartkarma Daily Briefs

Daily Brief Australia: Dropsuite Ltd, Airtasker, Readcloud Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Dropsuite (DSE AU): NinjaOne’s A$5.90/Share Scheme
  • Airtasker Ltd – Revenue momentum continues
  • Readcloud Ltd – A strong start to the year


Dropsuite (DSE AU): NinjaOne’s A$5.90/Share Scheme

By David Blennerhassett

  • Dropsuite (DSE AU), a backup, recovery and protection software company, has entered into a Scheme Implementation Deed with Texas-based IT automation outfit NinjaOne.
  • NinjaOne is offering A$5.90/share, a 34.1% premium to last close. Apart from Dropsuite’s shareholder approval, the Offer requires FIRB signing off. The Offer has the unanimous backing of both boards. 
  • The Offer also has the backing of Dropsuite’s largest shareholder, Topline Capital (31%). Board & management hold a further 9%.  Implementation is expected late May 2025. This is done. 

Airtasker Ltd – Revenue momentum continues

By Research as a Service (RaaS)

  • RaaS has published an update report on online marketplace Airtasker (ASX:ART) following its Q2 FY25 results release which demonstrated continued momentum in revenue growth across all regions.
  • All regions saw increased revenue (US marketplace revenue +278%, UK +95% and Australia +~13%) and all were at or above the Q1 FY25 growth rates, aided by increased marketing spend.
  • After all cash outflows ART achieved positive cash flow of $0.54m for the quarter, resulting in increased cash at bank (to $18.3m at December 31).

Readcloud Ltd – A strong start to the year

By Research as a Service (RaaS)

  • RaaS Research has published an update on edtech group ReadCloud (ASX:RCL) following the release of its Q1 results in which it reported a 26% increase in cash receipts to $2.4m.
  • The result was in line with our forecasts from an operating cash flow and ending cash position.
  • The company’s commentary was positive and gave us confident of our forecasts for the remainder of FY25 and into FY26.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Hanwha Ocean , TXR Robotics, Naver Corp and more

By | Daily Briefs, South Korea

In today’s briefing:

  • SOL Shipbuilding Top 3 ETF Throws off Some Serious Flow Trading Plays with Plenty of Juice
  • TXR Robotics IPO Valuation Analysis
  • Naver: CHZZK Increasing Market Share in the Korean Live Game Streaming Sector


SOL Shipbuilding Top 3 ETF Throws off Some Serious Flow Trading Plays with Plenty of Juice

By Sanghyun Park

  • This 20% reversion and 30% cap setup creates solid flow trades. With just 13 holdings, SOL ETF’s weight swings hard—Hanwha Ocean’s already pushing 27% post-rebal.
  • Constituent changes drive the biggest dislocations—still the main setup. “The other 10” names are FICS-screened by market cap (May/Nov cut), making rotations fairly predictable.
  • With AUM only ramping recently, this ETF is still in price discovery mode. Pre-positioning ahead of flows has juice, making it a prime target for aggressive flow trading.

TXR Robotics IPO Valuation Analysis

By Douglas Kim

  • According to our valuation analysis, it suggests a base case implied price of 19,673 won per share (46% higher than the high end of the IPO price range).
  • Our base case valuation is based on target P/S of 5.4x using our estimated sales of 57.7 billion won.
  • To value TXR Robotics, the target P/S of 5.4x is based on a 30% discount to the comps’ valuation multiple.

Naver: CHZZK Increasing Market Share in the Korean Live Game Streaming Sector

By Douglas Kim

  • Naver’s CHZZK has been increasing its market share in the Korean live game streaming sector. This improving momentum is likely to continue to positively impact Naver’s share price. 
  • CHZZK was the top ranking live streaming platform in Korea in December 2024 with about 2.5 million MAU.
  • Naver is currently trading at EV/EBITDA of 11.4x and P/E of 18.3x, which are 50% and 51% lower respectively than its historical average valuation multiples from 2020 to 2023.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Sumber Alfaria Trijaya Tbk Pt and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Sumber Alfaria Trijaya (AMRT IJ) – Renewing Strategies for 2025


Sumber Alfaria Trijaya (AMRT IJ) – Renewing Strategies for 2025

By Angus Mackintosh

  • Sumber Alfaria Trijaya is set to book a strong finish to the year, with revenues on track to meet guidance and 4Q benefiting from supplier rebates and seasonal festivities.
  • The company is guiding for revenue growth in 2025 in line with that of 2024, with a plan to open at least 1,000 new Alfamart stores during the year.
  • The guidance for Lawson and Alfamidi store expansion has yet to be announced but numbers are likely to be similar or higher than 2024. Valuations remain attractive versus growth expectations. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Whirlpool of India, Lumino Industries Ltd, Veritas Finance Ltd, Krishca Strapping Solutions, Bajaj Finance Ltd, NIFTY Index and more

By | Daily Briefs, India

In today’s briefing:

  • Whirlpool Corporation’s Big Exit: What’s Behind the Stake Reduction?
  • Lumino Industries Ltd Pre-IPO Tearsheet
  • Veritas Finance Pre-IPO Tearsheet
  • Can Krishca Strapping Solutions Maintain Momentum Amidst Steel Price Volatility?
  • What the Airtel-Bajaj Finance Partnership Means for Their Growth Plans?
  • EQD | Nifty 50 Option Strategy – Implied Volatility Is Not as Rich as It Seems


Whirlpool Corporation’s Big Exit: What’s Behind the Stake Reduction?

By Nimish Maheshwari

  • Whirlpool Corp (WHR US) plans to sell a 31% stake in Whirlpool of India (WHIRL IN) reducing ownership to 20% by 2025, triggering a 20% decline due to valuation concerns.
  • The implied sale valuation is lower than market expectations, raising concerns about growth, profitability, and stock overvaluation, while the parent company capitalizes on an asset arbitrage opportunity.
  • Short-Term stock pressure due to stake sale overhang, declining profitability, and reduced parent control, but potential long-term re-rating if operational performance improves.

Lumino Industries Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Lumino Industries Ltd (0349204D IN) is looking to raise about US$116m in its upcoming India IPO. The bookrunners for the deal are Motilal, JM Fin, Monarch.
  • Lumino Industries Ltd (LIL) was established in 2005. The company is a product-driven integrated engineering, procurement, and construction (EPC) player in India.
  • As per CRISIL Report, Lumino Industries is recognized as the fastest-growing player in the conductors, power cables, and power EPC industry, in terms of revenue CAGR between FY22 to FY24.

Veritas Finance Pre-IPO Tearsheet

By Akshat Shah

  • Veritas Finance Ltd (1392490D IN) is looking to raise around US$323m in its upcoming India IPO. The bookrunners on the deal are ICICI, HDFC, Jefferies, Kotak and Nuvama.
  • Veritas Finance Limited (VFL) is a retail focused non-banking finance company (NBFC) in India primarily providing loans to micro small and medium enterprises (MSMEs) and self-employed individuals.
  • As per the CRISIL report, the firm was the fastest-growing NBFC in terms of AUM growth during FY22-24, growing at a CAGR of 61.76%.

Can Krishca Strapping Solutions Maintain Momentum Amidst Steel Price Volatility?

By Sudarshan Bhandari

  • Krishca Strapping Solutions (KRISHCA IN) is India’s first “Lead-Free” and eco-friendly production line for the heat treatment of steel strapping.
  • The company is aggressively pursuing growth, aiming for a 25% revenue increase in the current financial year and EBITDA margin is anticipated to stay between 15% and 20%
  • The company is investing in a new special steel production plant in Chennai and launching subsidiaries in the UAE and Singapore to tap into new markets

What the Airtel-Bajaj Finance Partnership Means for Their Growth Plans?

By Nimish Maheshwari

  • Airtel-Bajaj Finance partnership is a game-changer in the digital financial services sector in India. It combines the strengths of both companies to create a powerful platform.
  • By leveraging Airtel’s extensive distribution network and Bajaj Finance’s financial expertise, this collaboration has the potential to disrupt the market and challenge established players.
  • It follows the successful playbook of other global partnerships and demonstrates how digital platforms and financial institutions can work together to enhance financial accessibility

EQD | Nifty 50 Option Strategy – Implied Volatility Is Not as Rich as It Seems

By Gaudenz Schneider

  • NIFTY Index implied volatility could be seen as rich when compared to its own history and in comparison to realized volatility.
  • Putting implied volatility into context with NIFTY Index market levels and trends will lead to a different conclusion. Implied volatility is not nearly as rich as conventional measures suggest.
  • This Insight provides a quantitative indication at which price implied volatility can be assessed as rich, given current relative index levels.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Meta Platforms (Facebook), APi Group, At&T Inc, Verizon Communications, HCA Healthcare, Inc. , Nucor Corp, Guess? Inc, Talos Energy Inc, Aurion Biotech, Moog Inc Class A and more

By | Daily Briefs, United States

In today’s briefing:

  • Meta 4Q’24 Update
  • APi Group: Safety Services at Scale – [Business Breakdowns, EP.204]
  • AT&T: Will Its Fiber Infrastructure Expansion Be A Game-Changer Or A Costly Mistake? – Major Drivers
  • Verizon Communication & Its 5G Empire: Can Recent Technological Innovations Help Sustain Its Market Position? – Major Drivers
  • HCA Healthcare: Health Insurance Exchange Growth Driving Our ‘Outperform’ Rating! – Major Drivers
  • Nucor Corporation: Resilience & Growth in Plate Production Powering Our Optimism! – Major Drivers
  • GES: Snapping the Store: Shifting to Spring With Vigor; Reiterate Buy, $23 PT
  • Talos Energy Inc. – Estimate Update; Testing High-Impact Prospects in 1H25
  • Aurion Biotech (AURN):  Regenerative Eye Disease Biotech Filed for IPO Despite Investor Litigation
  • Moog Inc.: The Top 6 Influences on Its Performance for 2025 & the Future! – Major Drivers


Meta 4Q’24 Update

By MBI Deep Dives

  • In recent weeks, Meta stock has mostly been one-way street: up! That continued to be the case after-hours post 4Q’24 earnings.
  • Here are my highlights from today’s call. Daily Active People (DAP) across its Family of Apps (FOA) accelerated to 60 mn QoQ in 4Q’24.
  • It’s kind of mind boggling that Meta added 1 Billion DAP since 1Q’20.

APi Group: Safety Services at Scale – [Business Breakdowns, EP.204]

By Business Breakdowns

  • API Group, a provider of life, safety, and specialty services to buildings, has seen significant growth under CEO Ross Becker and with involvement from investor Sir Martin Franklin.
  • Started as a small plumbing company in the 1960s, now a global leader in fire protection, security, and building services
  • Shifted from one-off construction projects to recurring revenue model, with over 55% of revenue now recurring

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


AT&T: Will Its Fiber Infrastructure Expansion Be A Game-Changer Or A Costly Mistake? – Major Drivers

By Baptista Research

  • AT&T’s latest financial performance in the fourth quarter of 2024 shows a balanced overview of strengths and challenges that shape its investment profile.
  • Positively, the company has demonstrated solid growth in its core operations, particularly in the Mobility and Consumer Wireline segments.
  • Postpaid phone net additions totaled approximately 1.7 million with a service revenue growth of 3.5% for Mobility, contributing to AT&T likely leading the industry in postpaid phone churn for most of the past sixteen quarters.

Verizon Communication & Its 5G Empire: Can Recent Technological Innovations Help Sustain Its Market Position? – Major Drivers

By Baptista Research

  • Verizon Communications Inc.’s latest earnings release highlights a blend of strategic initiatives, market positioning, operational performance, and future outlook amidst both challenges and opportunities.
  • The results provide insights into Verizon’s growth trajectory, notably in the wireless, broadband, and emerging AI sectors, as well as operational efficiencies driving financial performance.
  • The company reported a successful financial year, with wireless service revenue growing by 3.1% and adjusted EBITDA by 2.1%.

HCA Healthcare: Health Insurance Exchange Growth Driving Our ‘Outperform’ Rating! – Major Drivers

By Baptista Research

  • HCA Healthcare concluded the fourth quarter of 2024 with robust business fundamentals, maintaining consistency with previous quarters.
  • The company displayed resilience amidst challenges, such as significant weather disruptions caused by hurricanes, and a stable operational environment underpinned a reasonable starting point for 2025.
  • The execution of efficient operational strategies has allowed the organization to stabilize operations in affected regions like North Carolina, Georgia, and West Florida.

Nucor Corporation: Resilience & Growth in Plate Production Powering Our Optimism! – Major Drivers

By Baptista Research

  • Nucor Corporation has delivered a mixed performance during its fourth quarter of 2024, marked by safety achievements and strategic growth investments alongside certain operational challenges.
  • On the positive front, Nucor reported its safest year in history with a notable reduction in workplace injuries, reflecting a strong corporate culture focusing on safety.
  • Financially, the company achieved earnings of $1.22 per share for the fourth quarter, contributing to an annual total of $8.46 per share.

GES: Snapping the Store: Shifting to Spring With Vigor; Reiterate Buy, $23 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, $23 price target and projections for Guess?
  • after visiting stores in the New York City metro area and Long Island.
  • With Guess?

Talos Energy Inc. – Estimate Update; Testing High-Impact Prospects in 1H25

By Water Tower Research

  • The Katmai West #2 appraisal well is expected to commence production toward the end of 2Q25.
  • Gross deliverability from the well, which encountered more than 400 feet of gross hydrocarbon pay in the primary reservoir objective, is estimated to be ~15-20 MBOE/d.
  • Performance from the Katmai West #1 well, together with the results from this well, has nearly doubled the estimated proved reserve ultimate recovery to ~50 million BOE (gross) and supports Talos’ total estimated resource potential of ~100 MMBOE (gross).

Aurion Biotech (AURN):  Regenerative Eye Disease Biotech Filed for IPO Despite Investor Litigation

By IPO Boutique

  • AURN001, is an improved formulation designed to be mechanistically identical to Vyznova and to provide enhanced benefits, including manufacturing scalability and extended shelf life.
  • There is pending litigation between Aurion Biotech and the company’s largest shareholder, Alcon Research.
  • This company is on a trajectory to set terms and debut in the first half of February.

Moog Inc.: The Top 6 Influences on Its Performance for 2025 & the Future! – Major Drivers

By Baptista Research

  • Moog Inc.’s first quarter fiscal 2025 results indicate a robust start to the year, with significant achievements in various segments of its business.
  • The company reported sales of $910 million, a 6% year-over-year increase, underscoring strong performance particularly in Military Aircraft, Commercial Aircraft, and Space and Defense, although Industrial sales declined due to divestitures and soft market conditions.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Global Food Creators, Takeda Pharmaceutical, Namura Shipbuilding, Hagihara Industries, Anritsu Corp, TSE Tokyo Price Index TOPIX, Financial Products Group Co, M&A Capital Partners, Okinawa Cellular Telephone and more

By | Daily Briefs, Japan

In today’s briefing:

  • Global Foods Creators (7559) – Another Stupidly Cheap MBO With Rigged DCF
  • Takeda Pharma (4502) – Strong Results
  • Quiddity JPX-Nikkei 400 Rebal 2025: End-Jan 2025 Ranks
  • Takeda Pharmaceutical (4502 JP): Strong Q3 Result Triggers Guidance Raise; ¥100B Buyback Announced
  • Hagihara Industries Inc. (7856 JP) Research update
  • Anritsu Corp (6754 JP): Q3 FY03/25 flash update
  • Is the Decline in Number of Listed Companies the Beginning of a Shift to Value-Creating Management?
  • Financial Products Group Co (7148 JP): Q1 FY09/25 flash update
  • M&A Capital Partners (6080 JP): Q1 FY09/25 flash update
  • Okinawa Cellular Telephone: Q3 FY03/25 flash update, revision of full-year earnings forecasts


Global Foods Creators (7559) – Another Stupidly Cheap MBO With Rigged DCF

By Travis Lundy

  • Today after the close, Global Food Creators (7559 JP) announced that the CEO would sell his 1.23% of the company into an MBO by a company he set up. 
  • The family company which owns 27%, and he would fund the takeover of the other 73% with 1% equity taken from his share sale, and 99% bank loans. 
  • The TOB is at 0.65x book for a cash-rich company. Liquidate the cash and the rest is being taken over at 0.33x book. Aaaaargh. 

Takeda Pharma (4502) – Strong Results

By Travis Lundy

  • Today Takeda Pharmaceutical (4502 JP) announced earnings which will mean last year was the trough, not this year. The pipeline looks OK too. 
  • The company also announced a ¥100bn buyback and a change of CEO. The buyback has a big number, but it isn’t particularly exciting. 
  • All in all, there’s positive news here, but it is all much of a muchness, but as it is a nine-figure buyback in 3mos, we take a look.

Quiddity JPX-Nikkei 400 Rebal 2025: End-Jan 2025 Ranks

By Janaghan Jeyakumar, CFA

  • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted capped index composed of 400 constituents.
  • The annual index review takes place in August every year. We look at the latest rankings of potential ADDs/DELs every month.
  • Below is a look at the rankings of potential ADDs/DELs for the JPX-Nikkei 400 August 2025 rebalance based on trading data as of end-January 2025.

Takeda Pharmaceutical (4502 JP): Strong Q3 Result Triggers Guidance Raise; ¥100B Buyback Announced

By Tina Banerjee

  • Takeda Pharmaceutical (4502 JP) reported better-than-expected performance in Q3FY25, with 3% revenue growth to ¥1,144B, driven by continued strong momentum from Growth and Launch Products. All key parameters beat estimates.
  • Takeda has upgraded its full year outlook for growth, reflecting strong year-to-date product performance and OPEX efficiencies, as well as revised foreign exchange assumptions. Takeda has also announced ¥100B buyback.
  • Continued strong performance of its Growth and Launch product portfolio, ripe late-stage pipeline, and expected margin improvement from FY26 envisage long-term growth prospect of the company.  

Hagihara Industries Inc. (7856 JP) Research update

By Nippon Investment Bespoke Research UK

  • Hagihara Industries reported FY24 (Oct year-end) earnings results on 10 December with FY24 operating profit [OP] of ¥2,097mil (+6.0% YoY) on sales of ¥33,118mil (+6.0% YoY) versus an OP target of ¥2,200mil (+11.2% YoY) on sales of ¥32,000mil (+2.4% YoY).
  • While sales overshot the firm’s guidance, OP fell short due to costs associated with a core system renewal and real estate acquisition tax incurred on the Kasaoka Factory.
  • Management is guiding for FY25 1H OP of ¥1,160mil (-8.8% YoY) on sales of ¥16,780mil (+2.5% YoY), and FY25 OP of ¥2,400mil (+14.4% YoY) on sales of ¥34,000mil (+2.7% YoY).

Anritsu Corp (6754 JP): Q3 FY03/25 flash update

By Shared Research

  • Orders reached JPY81.9bn (+2.3% YoY), revenue JPY80.8bn (+3.9% YoY), with operating profit at JPY6.4bn (+24.4% YoY).
  • Strong demand in the food industry increased segment operating profit by 126.3% YoY, with OPM rising 4.0pp YoY.
  • Full-year FY03/25 forecast remains unchanged; progress stands at 70.3% for revenue and 58.4% for operating profit.

Is the Decline in Number of Listed Companies the Beginning of a Shift to Value-Creating Management?

By Aki Matsumoto

  • While the number of listed companies worldwide has been on a declining trend, the TSE has experienced growth in market capitalization, but growth in market capitalization has been slow.
  • TSE requested companies to raise their P/B, but admits that many companies have yet to reach this goal and that it’ll take considerable time to change to such management style.
  • Shareholder proposals are increasing. This could hasten the shift to value-creating management, or companies that find it burdensome as a cost of listing may choose to go private.

Financial Products Group Co (7148 JP): Q1 FY09/25 flash update

By Shared Research

  • In Q1 FY09/25, revenues increased by 14.6% YoY, while operating and recurring profits decreased by 7.7% and 7.4% respectively.
  • The Leasing Fund Business reported a 26.5% YoY revenue decline, with a segment profit margin of 87.7%, down 1.2pp YoY.
  • The International Real Estate Fund Business achieved a 356.6% YoY revenue increase, with a gross profit margin of 90.6%, up 8.5pp YoY.

M&A Capital Partners (6080 JP): Q1 FY09/25 flash update

By Shared Research

  • Revenue in Q1 FY09/25 reached JPY7.3bn, a 131.8% YoY increase, driven by higher average fees per deal.
  • Operating profit and recurring profit both increased by 465.1% YoY to JPY3.3bn, with net income rising 465.7% YoY.
  • The company revised its dividend policy, increasing the payout ratio target to 30%, raising FY09/25 dividends to JPY51.84.

Okinawa Cellular Telephone: Q3 FY03/25 flash update, revision of full-year earnings forecasts

By Shared Research

  • For Q3 FY03/24, operating revenue was JPY62.4bn (+6.8% YoY), with net income JPY9.5bn (-1.0% YoY).
  • Capex for Q3 FY03/25 was JPY4.2bn, a 34.4% YoY decrease, with 66.3% progress against the full-year plan.
  • FY03/25 forecast revised: revenue JPY83.0bn (+6.4% YoY), operating expenses JPY65.5bn (+7.4% YoY), dividend JPY120/share.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Zephyrm Bioscience and more

By | China, Daily Briefs

In today’s briefing:

  • Pre-IPO Zephyrm Bioscience – Despite Promising Pipeline, Investment Risk Is High


Pre-IPO Zephyrm Bioscience – Despite Promising Pipeline, Investment Risk Is High

By Xinyao (Criss) Wang

  • There’s great potential for PSCs, which provides new treatment options for complex diseases where traditional therapies are ineffective.The more solid the platform technology, the greater the dividends in later stage.
  • Zephyrm’s pipeline candidates are promising. However, considering the R&D risks, the uncertainty of future commercialization and product safety profile, we think the investment risk of this Company is relatively high.
  • Valuation of overseas peers is not high. In our view, valuation performance of Zephyrm would be largely depend on its clinical results of pipeline, which is a gamble for investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Is the Decline in Number of Listed Companies the Beginning of a Shift to Value-Creating Management? and more

By | Daily Briefs, ESG

In today’s briefing:

  • Is the Decline in Number of Listed Companies the Beginning of a Shift to Value-Creating Management?


Is the Decline in Number of Listed Companies the Beginning of a Shift to Value-Creating Management?

By Aki Matsumoto

  • While the number of listed companies worldwide has been on a declining trend, the TSE has experienced growth in market capitalization, but growth in market capitalization has been slow.
  • TSE requested companies to raise their P/B, but admits that many companies have yet to reach this goal and that it’ll take considerable time to change to such management style.
  • Shareholder proposals are increasing. This could hasten the shift to value-creating management, or companies that find it burdensome as a cost of listing may choose to go private.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Lumino Industries Ltd Pre-IPO Tearsheet and more

By | Daily Briefs, ECM

In today’s briefing:

  • Lumino Industries Ltd Pre-IPO Tearsheet
  • Veritas Finance Pre-IPO Tearsheet
  • TXR Robotics IPO Valuation Analysis
  • Aurion Biotech (AURN):  Regenerative Eye Disease Biotech Filed for IPO Despite Investor Litigation
  • Beta Bionic Inc (BBNX): IPO Pops, Trades Strong on Opening Day
  • Pre-IPO Zephyrm Bioscience – Despite Promising Pipeline, Investment Risk Is High


Lumino Industries Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Lumino Industries Ltd (0349204D IN) is looking to raise about US$116m in its upcoming India IPO. The bookrunners for the deal are Motilal, JM Fin, Monarch.
  • Lumino Industries Ltd (LIL) was established in 2005. The company is a product-driven integrated engineering, procurement, and construction (EPC) player in India.
  • As per CRISIL Report, Lumino Industries is recognized as the fastest-growing player in the conductors, power cables, and power EPC industry, in terms of revenue CAGR between FY22 to FY24.

Veritas Finance Pre-IPO Tearsheet

By Akshat Shah

  • Veritas Finance Ltd (1392490D IN) is looking to raise around US$323m in its upcoming India IPO. The bookrunners on the deal are ICICI, HDFC, Jefferies, Kotak and Nuvama.
  • Veritas Finance Limited (VFL) is a retail focused non-banking finance company (NBFC) in India primarily providing loans to micro small and medium enterprises (MSMEs) and self-employed individuals.
  • As per the CRISIL report, the firm was the fastest-growing NBFC in terms of AUM growth during FY22-24, growing at a CAGR of 61.76%.

TXR Robotics IPO Valuation Analysis

By Douglas Kim

  • According to our valuation analysis, it suggests a base case implied price of 19,673 won per share (46% higher than the high end of the IPO price range).
  • Our base case valuation is based on target P/S of 5.4x using our estimated sales of 57.7 billion won.
  • To value TXR Robotics, the target P/S of 5.4x is based on a 30% discount to the comps’ valuation multiple.

Aurion Biotech (AURN):  Regenerative Eye Disease Biotech Filed for IPO Despite Investor Litigation

By IPO Boutique

  • AURN001, is an improved formulation designed to be mechanistically identical to Vyznova and to provide enhanced benefits, including manufacturing scalability and extended shelf life.
  • There is pending litigation between Aurion Biotech and the company’s largest shareholder, Alcon Research.
  • This company is on a trajectory to set terms and debut in the first half of February.

Beta Bionic Inc (BBNX): IPO Pops, Trades Strong on Opening Day

By IPO Boutique

  • The stock opened 29.4% above its issue price at $22.00 and closed its debut session at $23.63, delivering a first-day gain of 39.0%.
  • This was a major victory for the IPO market, marking the highest first-day percentage gain of the year.
  • Looking ahead, the IPO market’s next test will be from the biotech sector.

Pre-IPO Zephyrm Bioscience – Despite Promising Pipeline, Investment Risk Is High

By Xinyao (Criss) Wang

  • There’s great potential for PSCs, which provides new treatment options for complex diseases where traditional therapies are ineffective.The more solid the platform technology, the greater the dividends in later stage.
  • Zephyrm’s pipeline candidates are promising. However, considering the R&D risks, the uncertainty of future commercialization and product safety profile, we think the investment risk of this Company is relatively high.
  • Valuation of overseas peers is not high. In our view, valuation performance of Zephyrm would be largely depend on its clinical results of pipeline, which is a gamble for investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Initiating Coverage on SUZANO: Headline Risk Limits Upside Potential and more

By | Credit, Daily Briefs

In today’s briefing:

  • Initiating Coverage on SUZANO: Headline Risk Limits Upside Potential


Initiating Coverage on SUZANO: Headline Risk Limits Upside Potential

By Leandro Gubler

  • Within Suzano’s capital structure, we prefer the 3.750% 2031 and 3.125% 2032 bonds, as they compare favorably to select peers, the broader EM BBB Index, and the US BBB Index.
  • Uncertainty over Brazil’s economic outlook, including currency weakness and fiscal challenges, along with potential trade policy risks under the new US administration, increases headline risk and limits upside potential.
  • Suzano is the world’s largest producer of eucalyptus pulp and a leading integrated pulp and paper company.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars